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Effect of Particle Size on Bioavailability of Carbamazepine
Administered as a Nanoemulsion
Jinwon Byun, Derrick Chapman, Rebecca Kyper, Gina Mattes, and Zachary Wallace | Dr. Elisha Injeti | Cedarville University

Introduction
 Carbamazepine (CBZ) is an anticonvulsant drug
primarily used to treat epilepsy, bipolar disorder,
trigeminal and glossopharyngeal neuralgia.

 The study will be conducted as a randomized
controlled crossover experiment utilizing a rat
model.

 CBZ is a lipophilic and poorly soluble drug with
limited ability to diffuse across biological
membranes.

 Sprague-Dawley rats (n=12) will be divided
randomly into two groups of same size.

 To increase its bioavailability, CBZ is formulated
into specialized nanoemulsions called Self
Nano-Emulsifying Drug Delivery Systems
(SNEDDS).

 One group will be administered CBZ in standard
formulation and SNEDDS for other group.
 After administration, blood samples will be
collected at 5, 10, 15, 20, 30, 45, 60, 90, and 120
2
minutes .

 SNEDDS are isotropic mixtures of oil,
surfactants and cosurfactants that form fine oilin-water nanoemulsions upon mild agitation,
followed by injection into aqueous media of
gastrointestinal tract.

 Tail vein incision method will be used to collect
blood samples.

 SNEDDS have shown to reduce the particle size
of CBZ molecules and improve its solubility and
ability to cross the biological membranes1.

 CBZ in blood samples will be analyzed by reversed
phase High Performance Liquid Chromatography
(HPLC).

 However, the in-vivo bioavailability of CBZ in
SNEDDS hasn’t been investigated.

Objective
 The objective of this study is to study the effect of
particle size on in-vivo bioavailability of CBZ
administered as SNEDDS compared to a standard
formulation

Data Analysis

Experimental Methods

 Samples will be stored at -20°C until ready for
2
analysis .

Randomize Rats
into Two Groups

Analyze Data

Administer
Formulations to
Respective Groups

Crossover
Administration &
Collection

Collect Blood

Washout

Samples

Period

 An unpaired t-test will be used to compare the
significance between the two sets of data.

Results and Conclusions
 Bioavailability is expected to increase due to the
deceased particle size of SNEDDS formulation.
 Limitations include a small sample size which will
lower statistical power of the results.
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